From Nasdaq: 2025-06-05 03:19:00

Investing in top companies like Summit Therapeutics (NASDAQ: SMMT) and Axsome Therapeutics (NASDAQ: AXSM) after significant gains can still be beneficial. Summit Therapeutics’ shares have surged over 1,000% in the past three years due to promising results with ivonescimab, a cancer medicine. Axsome Therapeutics has also seen a 350% increase in stock value with successful clinical and regulatory milestones, including approvals for major depressive disorder and narcolepsy treatments. Both companies have strong potential for future growth and could be wise investments.

Summit Therapeutics’ ivonescimab has shown promising results in Phase 3 studies, potentially competing with Keytruda in non-small cell lung cancer. Axsome Therapeutics has secured approvals and positive trial results for various treatments, indicating a bright future. Both companies are positioned for growth and could offer significant returns to investors in the coming years. Consider investing in these biotechs for long-term success.



Read more at Nasdaq: 2 Soaring Stocks Wth More Upside Potential